Christina Leslie develops computational and statistical methods to study gene expression in normal cells and in cancer cells.
In an eagerly awaited study, Memorial Sloan Kettering researchers report on the molecular structure of mTOR, a protein commonly mutated in cancer.
Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.
Physician-scientist Siddhartha Mukherjee, author of The Emperor of All Maladies: A Biography of Cancer, spoke to 2013 graduates of the “tenderness and tension” inherent in scientific discovery.
Memorial Sloan Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.
Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.
Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.
Six students have successfully defended their dissertations and will receive their PhD degrees at Commencement on May 10.
A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.
Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.